Paper Details
- Home
- Paper Details
Original Abstract of the Article :
The analgesic efficacy of ketorolac tromethamine was compared to placebo in 126 patients suffering moderate or severe chronic pain due to cancer in a double-blind parallel randomized study. Ketorolac was administered intramuscularly in doses of 10, 30 or 90 mg. Pain intensity and pain relief were as...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1002/j.1552-4604.1989.tb03274.x
データ提供：米国国立医学図書館（NLM）
Ketorolac for Cancer Pain: A New Oasis in the Desert of Suffering
Cancer pain, a relentless desert of discomfort, can significantly impact the quality of life for patients. This research explores the effectiveness of ketorolac tromethamine, a non-steroidal anti-inflammatory drug (NSAID), in relieving cancer pain. The study conducted a double-blind, placebo-controlled trial to compare the analgesic effects of ketorolac to placebo in patients with moderate to severe chronic cancer pain. The researchers aimed to determine whether ketorolac is an effective treatment option for cancer pain and to assess its safety and tolerability.
Ketorolac: A Viable Option for Cancer Pain Relief
The study found that ketorolac, administered intramuscularly, was significantly more effective than placebo in reducing pain intensity and improving overall pain relief. The study also found that ketorolac was well-tolerated, with a low incidence of side effects. However, the study did not find a significant difference in effectiveness between different doses of ketorolac, suggesting that the optimal dose may vary depending on the individual patient.
Finding Relief from Cancer Pain
This research provides valuable insights into the use of ketorolac for cancer pain management. The study suggests that ketorolac is a viable option for patients with moderate to severe chronic cancer pain. If you are experiencing cancer pain, it's crucial to consult with your doctor to discuss the best treatment options for your individual needs. Ketorolac may offer a path to relief, but it's essential to work closely with your healthcare team to find the most appropriate and effective treatment for your specific situation.
Dr.Camel's Conclusion
Cancer pain is a harsh desert of suffering, but this research offers a glimmer of hope. Ketorolac, like a refreshing oasis, provides a potential source of relief for patients battling this debilitating condition.
Date :
- Date Completed 1990-01-31
- Date Revised 2019-08-24
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.